Cicardi, Marco <br/><br/>
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.  [electronic resource] 

 -  The New England journal of medicine  Aug 2010 
 - 532-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa0906393  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Angioedemas, Hereditary--drug therapy<br/>Bradykinin--administration & dosage<br/>Bradykinin B2 Receptor Antagonists<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Intention to Treat Analysis<br/>Male<br/>Statistics, Nonparametric<br/>Tranexamic Acid--therapeutic use